Z-0252-2013 Class II Terminated

Recalled by Diagnostica Stago, Inc. — Parsippany, NJ

FDA device recall Z-0252-2013 was initiated by Diagnostica Stago, Inc. on Jun 15, 2012 and is designated Class II. Reason for recall: Following a single customer complaint that incorrect INR values were occasionally printed for PT tests, even though the primary units (seconds) were correct, the firm investigated and confirmed the… The recall status is terminated (terminated Jul 19, 2013). Affected quantity: 232 units US; 5 units Canada.

Recall details

Product Type
Devices
Report Date
Nov 14, 2012
Initiation Date
Jun 15, 2012
Termination Date
Jul 19, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
232 units US; 5 units Canada

Product description

STA Satellite Automated Multi-Parameter Analyzer This system is a fully automatic clinical instrument indicated and intended for the performance of tests on human plasma, the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.

Reason for recall

Following a single customer complaint that incorrect INR values were occasionally printed for PT tests, even though the primary units (seconds) were correct, the firm investigated and confirmed the potential for printing incorrect secondary units when using an external printer and the customer printout mode on the STA Satellite¿.

Distribution pattern

Worldwide Distribution - USA (nationwide) and Canada

Code information

K082248 D089976 Ref 58104 units

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0252-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0252-2013. Report a data issue: hello@regdatalab.com.